A leading drugmaker ramped up its lobbying in Canada fivefold last year, urging government officials to enact a rule that would give it an effective monopoly on long-acting narcotic painkillers.
Health Canada has decided not to require controlled-release opioid painkillers to be tamper-resistant, saying that measure wouldn’t help Canada’s fastest-growing drug problem, which kills hundreds of people across the country each year.
August 10, 2015 – Anna Mehler Paperny, Global News
David Juurlink sees them daily — old and young, with strokes or pneumonia or broken bones or drug-related overdoses, accidents, constipation.
Their ailments and backgrounds and health conditions run the gamut. And they’re all on high doses of a drug five times more powerful than morphine.
Ontario needs to rethink the way it treats addiction and pain if it wants to tackle a worsening prescription opioid health crisis, critics say.
Preliminary figures obtained by Global News indicate opioids are killing more Ontarians than ever before – and the province has no plan to shift away from its one-drug crackdown even as the opioid crisis shifts to such less-notorious drugs as Fentanyl and Hydromorph Contin.
Nineteen thousand, two hundred and thirty-seven tablets.
That’s how many pills an Ontario pharmacy employee was able to steal before being caught in February – by far the biggest oxycodone theft reported from a Canadian hospital or pharmacy since January 2012, according to numbers Health Canada gave Global News.